Brief: InDex Pharmaceuticals Q2 Operating Loss Widens To SEK 42.6 Mln

Flerie AB

25/08/2021 07:07

Aug 25 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * Q2 OPERATING LOSS SEK 42.6 MILLION VERSUS LOSS SEK 15.6
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr1M1KsY 
Further company coverage:  INDEX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))